Benzinga | Nov 4, 2020 04:51PM EST

Mirati Therapeutics Q3 EPS $(1.96) Down From $(1.38) YoY, Sales $11.42M Up From $988.00K YoY

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(1.96) per share. This is a 42.03 percent decrease over losses of $(1.38) per share from the same period last year. The company reported $11.42 million in sales this quarter. This is a 1.06K percent increase over sales of $988.00 thousand the same period last year.